HO/sup +/
Developments in administration of growth hormone treatment: focus on Norditropin<sup>®</sup> Flexpro<sup>®</sup>
8
The NordiNet<sup>®</sup> International Outcome Study and NovoNet<sup>®</sup> ANSWER Program<sup>®</sup>: rationale, design, and methodology of two international pharmacoepidemiological registry-based studies monitoring long-term clinical and safety outcomes of growth hormone therapy (Norditropin<sup>®</sup>)
9
Implicating SCF Complexes in Organogenesis in Caenorhabditis elegans
24
Distribution of CD4<sup>+</sup> and CD8<sup>+</sup> exhausted tumor-infiltrating lymphocytes in molecular subtypes of Chinese breast cancer patients
7
Optical bench performance of AcrySof<sup>®</sup> IQ ReSTOR<sup>®</sup>, AT LISA<sup>®</sup> tri, and FineVision<sup>®</sup> intraocular lenses
9
<p>An integrated safety analysis of combined acetaminophen and ibuprofen (Maxigesic<sup>®</sup>/ Combogesic<sup>®</sup>) in adults</p>
14
<em>N</em>-n-butyl haloperidol iodide inhibits H<sub>2</sub>O<sub>2</sub>- induced Na<sup>+</sup>/Ca<sup>2+</sup>-exchanger activation via the Na<sup>+</sup>/H<sup>+</sup> exchanger in rat ventricular myocytes
11
Central aortic blood pressure and augmentation index: comparison between Vasotens<sup>®</sup> and SphygmoCor<sup>®</sup> technology
7
Cost-effectiveness analysis of Mammostrat<sup>®</sup> compared with Oncotype DX<sup>®</sup> to inform the treatment of breast cancer
11
Azithromycin in DuraSite<sup>®</sup> for the treatment of blepharitis
8
Plerixafor for autologous CD34<sup>+</sup> cell mobilization
7
Aterofisiol<sup>®</sup> in carotid plaque evolution
8
Changes in the number of CD31<sup>−</sup>CD45<sup>−</sup>Sca-1<sup>+</sup> cells and Shh signaling pathway involvement in the lungs of mice with emphysema and relevant effects of acute adenovirus infection
12
Prospective, randomized, fellow eye comparison of WaveLight<sup>®</sup> Allegretto Wave<sup>®</sup> Eye-Q versus VISX CustomVue<sup>TM</sup> STAR S4 IR<sup>TM </sup>in photorefractive keratectomy: analysis of visual outcomes and higher-order aberrations
9
Asthma patients prefer Respimat<sup>®</sup> Soft Mist<sup>™</sup> Inhaler to Turbuhaler<sup>®</sup>
8
An evaluation of the accuracy of the ORange<sup>®</sup> (Gen II) by comparing it to the IOLMaster<sup>®</sup> in the prediction of postoperative refraction
5
Tiotropium HandiHaler<sup>® </sup>and Respimat<sup>®</sup> in COPD: a pooled safety analysis
21
Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat<sup>® </sup>or HandiHaler<sup>®</sup>
12
p27<sup>Kip1</sup> and Ser10-phosphorylated p27<sup>Kip1</sup> in breast cancer: clinical significance and expression
7
Measurement of D*<sup>±</sup>, D<sup>±</sup> and D<inf>s</inf><sup>±</sup> meson production cross sections in pp collisions at s√=7 TeV with the ATLAS detector
47